Press Releases

November 20, 2019 Press Release
Congressional Internet Caucus Co-Chairs Commemorate First Internet Message
November 20, 2019 Press Release
Legislation Tackles Youth Tobacco Epidemic and Maternal Mortality
Legislation Tackles Youth Tobacco Epidemic and Maternal Mortality
November 20, 2019 Press Release
Provisions of Eshoo’s TRUE Fees Act and Modern Television Act Pass the Committee, Along with an Amendment to Protect Privacy
November 14, 2019 Press Release

Legislation Holds Telephone, Cable, and Internet Providers Accountable

November 5, 2019 Press Release

Silicon Valley Congresswomen Propose Creating Strong Set of User Rights, Establishing Digital Privacy Agency & Placing Privacy Obligations on Tech Companies

November 1, 2019 Press Release

Representatives lead 23 California Members in Call to Action After Dangerous Network Outages

October 31, 2019 Press Release

Backdoors threaten Americans’ security

WASHINGTON, D.C.—Today, Representative Anna G. Eshoo (CA-18) and Senator Ron Wyden (Ore.) sent a letter to Attorney General William P. Barr urging him to immediately cease requests for government backdoors and discouraging encryption online.

October 30, 2019 Press Release
WASHINGTON, D.C. — Congresswoman Anna G. Eshoo (D-CA), the only Armenian-Assyrian Member of Congress, led the bipartisan effort to bring H.Res. 296 to the floor of the House to formally recognize the Armenian Genocide. The resolution passed on a bipartisan vote of 405 to 11.
October 30, 2019 Press Release
WASHINGTON, D.C.—Today, Congresswoman Anna G. Eshoo (CA-18) and Congressman Mike Thompson (CA-05) introduced the Smoke Planning and Research Act to help state and local governments protect their communities from the public risks of wildfire smoke. The bill is the House companion to legislation introduced by Senators Jeff Merkley (D-OR) and Ron Wyden (D-OR).
October 30, 2019 Press Release

WASHINGTON, D.C.— Today, Energy and Commerce Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) held a hearing to address the inadequacies of the global pharmaceutical supply chain and the broken generic drug industry.

Pages